Evidence map›Paper›PMID 28783105›Full record

ArticleViruses2017

Viral Ubiquitin Ligase Stimulates Selective Host MicroRNA Expression by Targeting ZEB Transcriptional Repressors.

Gabriel Lutz, Igor Jurak, Eui Tae Kim, Ju Youn Kim, Michael Hackenberg, Andrew Leader, Michelle L Stoller, Donna M Fekete, Matthew D Weitzman, Donald M Coen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Gabriel LutzDepartment of Microbiology, New York University School of Medicine, New York, NY 10016, USA. Gabriel.Lutz@med.nyu.edu.
Igor JurakDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. jyk294@gmail.com.
Eui Tae KimDepartment of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine and The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Andrew.Leader@icahn.mssm.edu.
Ju Youn KimDepartment of Microbiology, New York University School of Medicine, New York, NY 10016, USA. igor.jurak@biotech.uniri.hr.
Michael HackenbergDepartment of Genetics, Computational Genomics and Bioinformatics Group, University of Granada, Granada 18071, Spain. don_coen@hms.harvard.edu.
Andrew LeaderDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. kime2@email.chop.edu.
Michelle L StollerDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA. weitzmanm@email.chop.edu.
Donna M FeketeDepartment of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA. hackenberg@go.ugr.es.
Matthew D WeitzmanDepartment of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine and The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. mstoller2@gmail.com.
Donald M CoenDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. dfekete@purdue.edu.
Angus C WilsonDepartment of Microbiology, New York University School of Medicine, New York, NY 10016, USA. angus.wilson@med.nyu.edu.
Harvard University · USNew York University · USChildren's Hospital of Philadelphia · USPurdue University West Lafayette · USUniversidad de Granada · ES

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI Andrea L Kasinski · 1985 to 2026
$43.4M
MEDICAL SCIENTIST TRAININGT32GM007308 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 1985 to 2019
$23.2M
VIral and host mechanisms that tilt the HSV lytic/latent balanceP01AI098681 · NIAID · HARVARD MEDICAL SCHOOL · PI COEN, DONALD M · 2013 to 2023
$19.2M
VIRAL AND CELLULAR GENES IN HSV LATENCY AND REACTIVATIONP01NS035138 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI COEN, DAVID · 1996 to 2010
$15.0M
TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
INFECTIOUS DISEASES &BASIC MICROBIOLOGICAL MECHANISMST32AI007180 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 1985 to 2022
$8.9M
DEVELOPMENT STUDIES OF THE INNER EARR01DC002756 · NIDCD · PURDUE UNIVERSITY WEST LAFAYETTE · PI FEKETE, DONNA M · 1995 to 2019
$6.8M
MECHANISMS REGULATING HSV TK EXPRESSION DURING INFECTIONR01AI026126 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI COEN, DONALD M · 1988 to 2010
$3.2M
Role of DNA damage in the early steps of HSV infection and latency in neuronsR01NS082240 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI WEITZMAN, MATTHEW D. · 2013 to 2017
$2.0M
Antagonizing miRNAs in a strategy to cure HSV latencyR21AI105896 · NIAID · HARVARD MEDICAL SCHOOL · PI COEN, DONALD M · 2013 to 2014
$492k
New tools to study the dynamics of HSV latency and reactivation in living neuronsR21AI103933 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MOHR, IAN J, WILSON, ANGUS C · 2013 to 2014
$451k
Gene Transfer Tools for Delivery and Investigation of Inner Ear MicroRNAsF31DC011687 · NIDCD · PURDUE UNIVERSITY · PI STOLLER, MICHELLE LYNN · 2011 to 2014
$124k
NCI NIH HHS P30 CA023168NIAID NIH HHS P01 AI098681NIAID NIH HHS R01 AI026126NIAID NIH HHS R21 AI103933NIAID NIH HHS R21 AI105896NIAID NIH HHS T32 AI007180NIAID NIH HHS T32 AI007647NIDCD NIH HHS F31 DC011687NIDCD NIH HHS R01 DC002756NIGMS NIH HHS T32 GM007308NINDS NIH HHS P01 NS035138NINDS NIH HHS R01 NS082240
6 · The paper itself

Abstract

Infection with herpes simplex virus-1 (HSV-1) brings numerous changes in cellular gene expression. Levels of most host mRNAs are reduced, limiting synthesis of host proteins, especially those involved in antiviral defenses. The impact of HSV-1 on host microRNAs (miRNAs), an extensive network of short non-coding RNAs that regulate mRNA stability/translation, remains largely unexplored. Here we show that transcription of the miR-183 cluster (miR-183, miR-96, and miR-182) is selectively induced by HSV-1 during productive infection of primary fibroblasts and neurons. ICP0, a viral E3 ubiquitin ligase expressed as an immediate-early protein, is both necessary and sufficient for this induction. Nuclear exclusion of ICP0 or removal of the RING (really interesting new gene) finger domain that is required for E3 ligase activity prevents induction. ICP0 promotes the degradation of numerous host proteins and for the most part, the downstream consequences are unknown. Induction of the miR-183 cluster can be mimicked by depletion of host transcriptional repressors zinc finger E-box binding homeobox 1 (ZEB1)/-crystallin enhancer binding factor 1 (δEF1) and zinc finger E-box binding homeobox 2 (ZEB2)/Smad-interacting protein 1 (SIP1), which we establish as new substrates for ICP0-mediated degradation. Thus, HSV-1 selectively stimulates expression of the miR-183 cluster by ICP0-mediated degradation of ZEB transcriptional repressors.

Indexed as

Host-Pathogen InteractionsCell NucleusCells, CulturedFibroblastsGene Expression RegulationHerpesvirus 1, HumanHumansImmediate-Early ProteinsMicroRNAsNerve Tissue ProteinsNeuronsProtein BindingProteolysisRNA-Binding ProteinsUbiquitin-Protein LigasesVirus ReplicationGEMIN2 protein, humanImmediate-Early ProteinsMicroRNAsMirn182 microRNA, humanMIRN183 microRNA, humanMIRN96 microRNA, humanNerve Tissue ProteinsRNA-Binding ProteinsUbiquitin-Protein LigasesVmw110 protein, Human herpesvirus 1ZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1E3 ubiquitin ligaseherpes simplex virushost shutoffHSV-1ICP0microRNAmiR-182miR-183miR-96ZEB

Identifiers

PMID28783105
PMCPMC5580467
OpenAlexW2742689146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.